Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 4
2013 6
2014 3
2015 5
2016 5
2017 7
2019 8
2020 10
2021 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Digestive System Neuroendocrine Tumor G1"
Page 1
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.
Citterio D, Coppa J, Sposito C, Busset MDD, Virdis M, Pezzoli I, Mazzaferro V. Citterio D, et al. Curr Treat Options Oncol. 2023 Nov;24(11):1651-1665. doi: 10.1007/s11864-023-01124-w. Epub 2023 Oct 26. Curr Treat Options Oncol. 2023. PMID: 37882889 Free PMC article. Review.
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver, to improve prognosis and quality of life in cancer patients. In unresectable, liver-only metastases from neuroendocrine tumors (NETs) of the …
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver, to improve progno …
Transanal minimally invasive surgery for rectal neuroendocrine tumors.
Hayashi S, Takayama T, Ikarashi M, Hagiwara K, Matsuno Y, Suzuki T. Hayashi S, et al. Surg Endosc. 2021 Dec;35(12):6746-6753. doi: 10.1007/s00464-020-08178-z. Epub 2020 Nov 25. Surg Endosc. 2021. PMID: 33237462
BACKGROUND: There is no literature that mainly searched for rectal neuroendocrine tumor (rNET) using transanal minimal invasive surgery (TAMIS). ...The median surgical duration was 80.5 (53-124) minutes and the median blood loss was 1 (1-12) ml. All removed tumor …
BACKGROUND: There is no literature that mainly searched for rectal neuroendocrine tumor (rNET) using transanal minimal invasiv …
Clinical outcomes and risk factors associated with poor prognosis after endoscopic resection of 10-20 mm rectal neuroendocrine tumors: a multicenter, retrospective study of 10-year experience.
Goo JJ, Baek DH, Kim HW, Lee HS, Lee JY, Park SB, Song GA, Lee SH, Lee JH; Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS). Goo JJ, et al. Surg Endosc. 2023 Jul;37(7):5196-5204. doi: 10.1007/s00464-023-09999-4. Epub 2023 Mar 22. Surg Endosc. 2023. PMID: 36947224
BACKGROUND: The efficacy of endoscopic resection for of 10-20 mm rectal neuroendocrine tumor (NET) remains controversial. We aimed to evaluate the clinical outcomes and risk factors associated with poor prognosis after endoscopic resection of 10-20 mm rectal NET and …
BACKGROUND: The efficacy of endoscopic resection for of 10-20 mm rectal neuroendocrine tumor (NET) remains controversial. We a …
Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A, Hirabayashi K, Yamada M, Kawanishi A, Takanashi Y, Kawaguchi Y, Nakagohri T, Nakamura N, Mine T. Hadano A, et al. Pancreatology. 2016 May-Jun;16(3):411-5. doi: 10.1016/j.pan.2016.01.011. Epub 2016 Feb 9. Pancreatology. 2016. PMID: 26905832
BACKGROUND: Pancreatic neuroendocrine microadenomas (pNEMAs) are neuroendocrine tumors measuring <5 mm in diameter. They are considered the precursor of pancreatic neuroendocrine tumors (pNETs). The aim of this study was to investigate the im …
BACKGROUND: Pancreatic neuroendocrine microadenomas (pNEMAs) are neuroendocrine tumors measuring <5 mm in diameter. …
Intraoperative pancreatoscopy can improve the detection of skip lesions during surgery for intraductal papillary mucinous neoplasia: A pilot study.
Arnelo U, Valente R, Scandavini CM, Halimi A, Mucelli RMP, Rangelova E, Svensson J, Schulick RD, Torphy RJ, Fagerström N, Moro CF, Vujasinovic M, Matthias Löhr J, Del Chiaro M. Arnelo U, et al. Pancreatology. 2023 Sep;23(6):704-711. doi: 10.1016/j.pan.2023.06.006. Epub 2023 Jun 12. Pancreatology. 2023. PMID: 37336668 Free article.
RESULTS: In total, 46 patients, 48% females, mean age (range) 67 years (45-82 years) underwent intraoperative pancreatoscopy. No mortality or procedure related complications were observed. Pancreatoscopy changed the operative course in 30 patients (65%), leading to extende …
RESULTS: In total, 46 patients, 48% females, mean age (range) 67 years (45-82 years) underwent intraoperative pancreatoscopy. No mortality o …
Clinical characteristics and prognostic factors of gastroenteropancreatic neuroendocrine tumors: a single center experience in China.
Hu HK, Ke NW, Li A, Du XJ, Guo Q, Hu WM. Hu HK, et al. Hepatogastroenterology. 2015 Jan-Feb;62(137):178-83. Hepatogastroenterology. 2015. PMID: 25911892
BACKGROUND/AIMS: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a unique subgroup of tumors in the digestive system but with great clinical heterogeneity. ...Abdominal pain occurred in 46.5% patients which was the most common initia …
BACKGROUND/AIMS: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a unique subgroup of tumors in the dige …
Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S, Jiang Y, Wang W, Zhan Q, Deng X, Shen B. Zou S, et al. Int J Surg. 2020 Feb;74:86-91. doi: 10.1016/j.ijsu.2019.12.034. Epub 2020 Jan 9. Int J Surg. 2020. PMID: 31926324 Free article.
The novel scoring system for recurrence risk classification sorted patients into three groups: score<15.4 for low risk (79.0%, 3- and 5-year recurrence risk 0.8% and 4.3%, median DFS not reached), score>15.4, <24.5 for intermediate risk (20.8% …
The novel scoring system for recurrence risk classification sorted patients into three groups: score<15.4 for low ri …
Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G. Rindi G, et al. Endocr Relat Cancer. 2013 Dec 16;21(1):1-16. doi: 10.1530/ERC-13-0246. Print 2014 Feb. Endocr Relat Cancer. 2013. PMID: 24344249
Lung neuroendocrine tumors are catalogued in four categories by the World Health Organization (WHO 2004) classification. ...The combination of these three variables resulted in a simple and effective grading system. A three-tiers grading system based o …
Lung neuroendocrine tumors are catalogued in four categories by the World Health Organization (WHO 2004) classification. ...Th …
Double-Balloon Enteroscopy in Detecting Small-Bowel Neuroendocrine Neoplasms: A Single-Center Prospective Study.
Rossi RE, Elli L, Branchi F, Conte D, Massironi S. Rossi RE, et al. Digestion. 2021;102(5):722-730. doi: 10.1159/000511850. Epub 2020 Dec 23. Digestion. 2021. PMID: 33361694
BACKGROUND AND AIM: Small-bowel neuroendocrine neoplasm (sbNEN) diagnosis has improved with double-balloon enteroscopy (DBE). ...Further studies are needed to better clarify the diagnostic role of DBE in the neuroendocrine tumor setting and its relationship w …
BACKGROUND AND AIM: Small-bowel neuroendocrine neoplasm (sbNEN) diagnosis has improved with double-balloon enteroscopy (DBE). ...Furt …
Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
Nießen A, Bergmann F, Hinz U, Schimmack S, Hackert T, Büchler MW, Strobel O. Nießen A, et al. Eur J Surg Oncol. 2020 Jun;46(6):1088-1096. doi: 10.1016/j.ejso.2020.01.030. Epub 2020 Jan 30. Eur J Surg Oncol. 2020. PMID: 32088004
BACKGROUND: Clinical management of duodenal neuroendocrine neoplasms (dNEN) is controversial. The aim of this study was to assess the outcome of surgical management and to identify risk factors for metastatic disease. ...Lymph node metastases were identified in 15 patients …
BACKGROUND: Clinical management of duodenal neuroendocrine neoplasms (dNEN) is controversial. The aim of this study was to assess the …
51 results